MYCN was discovered in 1983 by its tumor-driving role in neuroblastoma8,9, a tumor of the sympathetic nervous system, and mouse models, in which tumors were initiated by amplification or forced expression of MYCN, were neuroblastoma models. The gene discussed is MYCN; the disease is neoplasm.